跳至主要内容
临床试验/NCT00278239
NCT00278239Unknown不适用

Study of Outcome of Children Previously Enrolled in European Trials of Treatment for Primitive Neuroectodermal Tumour (PNET)

Children's Cancer and Leukaemia Group20 个研究点 分布在 2 个国家开始时间: 2002年6月最近更新:
适应症

试验速览

阶段
不适用
发起方
试验地点
20
主要终点
Quality of life (QOL) as measured by QOL questionnaire

研究概览

简要总结

RATIONALE: Questionnaires that measure quality of life may improve the ability to plan treatment for patients with primitive neuroectodermal tumors.

PURPOSE: This phase III trial is studying quality of life in patients who have undergone previous treatment for primitive neuroectodermal tumors.

详细描述

OBJECTIVES:

Primary

  • Determine the quality of survival of patients in the UK and other European countries enrolled in previous International Society of Pediatric Oncology (SIOP) 2 or 3 phase III trials for treatment of pediatric primitive neuroectodermal tumors (PNET).
  • Compare the quality of survival between children allocated to different treatments in these trials.

Secondary

  • Determine the framework that will allow similar information to be collected across all participating countries in the PNET 4 trial that opened in autumn 2002.

研究设计

研究类型
Observational

入排标准

年龄范围
3 Years 至 24 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Quality of life (QOL) as measured by QOL questionnaire

次要结局

  • Quality of survival compared among children undergoing different treatments by Health Utilities Index

研究者

发起方
Children's Cancer and Leukaemia Group
申办方类型
Other

研究点 (20)

Loading locations...

相似试验